Skip to content
Open access · OA via Europe PMC

Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status.

Raina S, Jain A, Thakur V, Balakrishnan A, Jamwal M, Bhatia P, Bansal D, Malhotra P, Das R, Sreedharanunni S.

Blood research · 2026

Abstract

<h4>Purpose</h4>Telomere(definition) length analysis (TLA) is used to identify telomere biology disorders (TBD) in aplastic anemia (AA); however, the diagnostic performance of quantitative PCR (qPCR)-based TLA across germline mutation categories remains poorly defined.<h4>Methods</h4>A total of 305 consecutive patients with AA were prospectively enrolled over 3.5 years. All patients underwent age-adjusted qPCR-based TLA and comprehensive germline sequencing, including whole exome sequencing or blended genome-exome sequencing, and were classified as having inherited bone marrow failure syndrome (IBMFS) (Category 1, n = 40), a monoallelic carrier state (Category 2, n = 19), a variant of uncertain significance (VUS; Category 3, n = 39), or AA without germline variants (Category 4, n = 207).<h4>Results</h4>Shortened telomere length (TL) (≤ 10th percentile) was present in 37.7% of patients, and very short TL (≤ 1st percentile) was present in 14.8%. The degree of shortening varied by etiology: 71.4% of confirmed TBD gene carriers had shortened TL compared with 31.6% of carriers of biallelic variants in Fanconi anemia pathway genes and 37.7% of patients with acquired AA. TL did not distinguish confirmed IBMFS from acquired AA across the full disease spectrum; however, normal TL (> 10th percentile) excluded TBD-associated IBMFS (TBD-IBMFS) with a negative predictive value of 98.5%. Very short TL (≤ 1st percentile) had a positive predictive value of only 12.9% for TBD-IBMFS and was also observed in 13.0% of acquired-AA patients.<h4>Conclusions</h4>In unselected patients with AA, qPCR-based TLA does not distinguish inherited from acquired disease across the full spectrum of IBMFS; however, normal TL substantially lowers the likelihood of TBD-IBMFS. Very short TL is not specific to constitutional telomeropathy and should be interpreted with caution when adjudicating TBD variants of uncertain significance.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1007/s44313-026-00182-x
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
S, R., A, J., V, T., A, B., M, J., P, B., D, B., P, M., R, D., &amp; S., S. (2026). Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status. <em>Blood research</em>. https://doi.org/10.1007/s44313-026-00182-x
Vancouver
S R, A J, V T, A B, M J, P B, et al. Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status. Blood research. 2026. doi:10.1007/s44313-026-00182-x.
BibTeX
@article{raina2026Telome, title = {Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status.}, author = {Raina S and Jain A and Thakur V and Balakrishnan A and Jamwal M and Bhatia P and Bansal D and Malhotra P and Das R and Sreedharanunni S.}, journal = {Blood research}, year = {2026}, doi = {10.1007/s44313-026-00182-x}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings